|
1
|
Yang L, Parkin DM, Li LD, Chen YD and Bray
F: Estimation and projection of the national profile of cancer
mortality in China: 1991–2005. Br J Cancer. 90:2157–2166.
2004.PubMed/NCBI
|
|
2
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
|
3
|
Roder DM: The epidemiology of gastric
cancer. Gastric Cancer. 5(Suppl 1): S5–S11. 2002. View Article : Google Scholar
|
|
4
|
Fukata M and Abreu MT: Role of Toll-like
receptors in gastrointestinal malignancies. Oncogene. 27:234–243.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Whitehead R, Truelove SC and Gear MW: The
histological diagnosis of chronic gastritis in fibreoptic
gastroscope biopsy specimens. J Clin Pathol. 25:1–11. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liew FY, Xu D, Brint EK and O'Neill LA:
Negative regulation of toll-like receptor-mediated immune
responses. Nat Rev Immunol. 5:446–458. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kondo T, Kawai T and Akira S: Dissecting
negative regulation of Toll-like receptor signaling. Trends
Immunol. 33:449–458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun H, Gong S, Carmody RJ, Hilliard A, Li
L, Sun J, Kong L, Xu L, Hilliard B, Hu S, et al: TIPE2, a negative
regulator of innate and adaptive immunity that maintains immune
homeostasis. Cell. 133:415–426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li D, Song L, Fan Y, Li X, Li Y, Chen J,
Zhu F, Guo C, Shi Y and Zhang L: Down-regulation of TIPE2 mRNA
expression in peripheral blood mononuclear cells from patients with
systemic lupus erythematosus. Clin Immunol. 133:422–427. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang G, Hao C, Lou Y, Xi W, Wang X, Wang
Y, Qu Z, Guo C, Chen Y and Zhang Y: Tissue-specific expression of
TIPE2 provides insights into its function. Mol Immunol.
47:2435–2442. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang L, Shi Y, Wang Y, Zhu F, Wang Q, Ma
C, Chen YH and Zhang L: The unique expression profile of human
TIPE2 suggests new functions beyond its role in immune regulation.
Mol Immunol. 48:1209–1215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y,
Qu Z, Cui J, Zhang G, Liang X, et al: Roles of TIPE2 in hepatitis B
virus-induced hepatic inflammation in humans and mice. Mol Immunol.
48:1203–1208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kong L, Liu K, Zhang Y-Z, Jin M, Wu BR,
Wang WZ, Li W, Nan YM and Chen YH: Downregulation of TIPE2 mRNA
expression in peripheral blood mononuclear cells from patients with
chronic hepatitis C. Hepatol Int. 7:844–849. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Q, Zhao M, Dong T, Zhou C, Peng Y,
Zhou X, Fan B, Ma W, Han M and Liu S: Tumor necrosis
factor-α-induced protein-8 like-2 (TIPE2) upregulates p27 to
decrease gastic cancer cell proliferation. J Cell Biochem.
116:1121–1129. 2015. View Article : Google Scholar
|
|
16
|
Negishi H, Ohba Y, Yanai H, Takaoka A,
Honma K, Yui K, Matsuyama T, Taniguchi T and Honda K: Negative
regulation of Toll-like-receptor signaling by IRF-4. Proc Natl Acad
Sci USA. 102:15989–15994. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pathak S, Ma S, Trinh L, Eudy J, Wagner
KU, Joshi SS and Lu R: IRF4 is a suppressor of c-Myc induced B cell
leukemia. PLoS One. 6:e226282011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fanzo JC, Hu CM, Jang SY and Pernis AB:
Regulation of lymphocyte apoptosis by interferon regulatory factor
4 (IRF-4). J Exp Med. 197:303–314. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Budwit-Novotny DA, McCarty KS, Cox EB,
Soper JT, Mutch DG, Creasman WT, Flowers JL and McCarty KS Jr:
Immunohistochemical analyses of estrogen receptor in endometrial
adenocarcinoma using a monoclonal antibody. Cancer Res.
46:5419–5425. 1986.PubMed/NCBI
|
|
20
|
Wang H, Sun Y, Liu S, Yu H, Li W, Zeng J,
Chen C and Jia J: Upregulation of progranulin by Helicobacter
pylori in human gastric epithelial cells via p38MAPK and MEK1/2
signaling pathway: Role in epithelial cell proliferation and
migration. FEMS Immunol Med Microbiol. 63:82–92. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hartwell LH and Kastan MB: Cell cycle
control and cancer. Science. 266:1821–1828. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Woodburn JR: The epidermal growth factor
receptor and its inhibition in cancer therapy. Pharmacol Ther.
82:241–250. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer: Trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ferrara N: Role of vascular endothelial
growth factor in physiologic and pathologic angiogenesis:
Therapeutic implications. Semin Oncol. 29(Suppl 16): S10–S14. 2002.
View Article : Google Scholar
|
|
25
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gus-Brautbar Y, Johnson D, Zhang L, Sun H,
Wang P, Zhang S, Zhang L and Chen YH: The anti-inflammatory TIPE2
is an inhibitor of the oncogenic Ras. Mol Cell. 45:610–618. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu R: Interferon regulatory factor 4 and 8
in B-cell development. Trends Immunol. 29:487–492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Marecki S and Fenton MJ: The role of IRF-4
in transcriptional regulation. J Interferon Cytokine Res.
22:121–133. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jo SH and Ren R: IRF-4 suppresses BCR/ABL
transformation of myeloid cells in a DNA binding-independent
manner. J Biol Chem. 287:1770–1778. 2012. View Article : Google Scholar :
|
|
30
|
Wang WL, Liu W, Gong HY, Hong JR, Lin CC
and Wu JL: Activation of cytokine expression occurs through the
TNFα/NF-κB-mediated pathway in birnavirus-infected cells. Fish
Shellfish Immunol. 31:10–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grumont RJ and Gerondakis S: Rel induces
interferon regulatory factor 4 (IRF-4) expression in lymphocytes:
Modulation of interferon-regulated gene expression by rel/nuclear
factor kappaB. J Exp Med. 191:1281–1292. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sharma S, Mamane Y, Grandvaux N, Bartlett
J, Petropoulos L, Lin R and Hiscott J: Activation and regulation of
interferon regulatory factor 4 in HTLV type 1-infected T
lymphocytes. AIDS Res Hum Retroviruses. 16:1613–1622. 2000.
View Article : Google Scholar : PubMed/NCBI
|
